Research and development facilities
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSF223201000008I
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 5 $2,781,256 obligated
Award facts
- Combined order value
-
- $2,801,391 Current, with exercised options
- $2,842,306 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 3% used
- $100,000,000.00
- Maximum order
- $20,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- C118 Research And Development Facilities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency, to Brigham & Women's Hospital Inc., a leading academic medical center and research institution affiliated with Harvard Medical School. The $100,000,000 multiple-award IDC is for research and development services at FDA facilities, with no small business set-aside.
The contract has included several delivery orders for specialized medical research and clinical services in support of the FDA's public health mission. Task orders have involved providing communications expertise and planning for the agency's epidemiology initiatives, developing a Computerized Physician Order Entry (CPOE) system, and conducting research on the impact of FDA drug safety communications. These contracted services leverage Brigham & Women's Hospital's extensive capabilities in advanced biomedical research, innovative healthcare technology, and comprehensive clinical research across medical domains such as cardiovascular disease, cancer, and neuroscience.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSF223201000008I?
HHSF223201000008I was awarded to Brigham & Womens Hospital Inc. by Food and Drug Administration (Department of Health and Human Services) on September 30, 2009.
How much is contract HHSF223201000008I worth?
Orders under HHSF223201000008I have obligated $2,781,256. Their combined current value, with exercised options, is $2,801,391. Their combined potential value, with all options, is $2,842,306. HHSF223201000008I's own ceiling is $100,000,000. A single order can be worth up to $20,000,000.
How many orders have been placed under contract HHSF223201000008I?
5 orders have been placed under HHSF223201000008I, the latest on September 13, 2013.
Who can order from contract HHSF223201000008I?
HHSF223201000008I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSF223201000008I competed?
The extent of competition for HHSF223201000008I was full and open competition. The government received 12 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV